These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 2158468)
1. Diabetic neuropathy in db/db mice develops independently of changes in ATPase and aldose reductase. A biochemical and immunohistochemical study. Bianchi R; Marelli C; Marini P; Fabris M; Triban C; Fiori MG Diabetologia; 1990 Mar; 33(3):131-6. PubMed ID: 2158468 [TBL] [Abstract][Full Text] [Related]
2. Sciatic nerve ATPase activity is unaffected in diabetic mutant C57Bl/Ks (db/db) mice. Bianchi R; Boccasavia E; Vittadello M; Schiavinato A; Gorio A Diabetes; 1987 Sep; 36(9):1082-5. PubMed ID: 2956143 [TBL] [Abstract][Full Text] [Related]
3. Glutathione redox state is not the link between polyol pathway activity and myo-inositol-related Na+-K+-ATPase defect in experimental diabetic neuropathy. Carroll PB; Thornton BM; Greene DA Diabetes; 1986 Nov; 35(11):1282-5. PubMed ID: 3019809 [TBL] [Abstract][Full Text] [Related]
4. Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition. Lambourne JE; Brown AM; Calcutt N; Tomlinson DR; Willars GB Diabetologia; 1988 Jun; 31(6):379-84. PubMed ID: 2970984 [TBL] [Abstract][Full Text] [Related]
5. Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats. Raccah D; Coste T; Cameron NE; Dufayet D; Vague P; Hohman TC J Diabetes Complications; 1998; 12(3):154-62. PubMed ID: 9618071 [TBL] [Abstract][Full Text] [Related]
6. Adenosine triphosphatase activity in sciatic nerve tissue of streptozocin-induced diabetic rats with and without high dietary sucrose: effect of aldose reductase inhibitors. Sredy J; Flam BR; Sawicki DR Proc Soc Exp Biol Med; 1991 Jun; 197(2):135-43. PubMed ID: 1851565 [TBL] [Abstract][Full Text] [Related]
7. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro. Kim J; Kyriazi H; Greene DA Diabetes; 1991 May; 40(5):558-67. PubMed ID: 1850704 [TBL] [Abstract][Full Text] [Related]
8. Aldose reductase inhibition with imirestat-effects on impulse conduction and insulin-stimulation of Na+/K(+)-adenosine triphosphatase activity in sciatic nerves of streptozotocin-diabetic rats. Carrington AL; Ettlinger CB; Calcutt NA; Tomlinson DR Diabetologia; 1991 Jun; 34(6):397-401. PubMed ID: 1653157 [TBL] [Abstract][Full Text] [Related]
9. Neuropathy in diabetic mice overexpressing human aldose reductase and effects of aldose reductase inhibitor. Yagihashi S; Yamagishi SI; Wada Ri R; Baba M; Hohman TC; Yabe-Nishimura C; Kokai Y Brain; 2001 Dec; 124(Pt 12):2448-58. PubMed ID: 11701599 [TBL] [Abstract][Full Text] [Related]
10. In vitro correction of impaired Na+-K+-ATPase in diabetic nerve by protein kinase C agonists. Lattimer SA; Sima AA; Greene DA Am J Physiol; 1989 Feb; 256(2 Pt 1):E264-9. PubMed ID: 2537578 [TBL] [Abstract][Full Text] [Related]
11. Decreased myo-inositol content and Na+-K+-ATPase activity in superior cervical ganglion of STZ-diabetic rat and prevention by aldose reductase inhibition. Greene DA; Mackway AM Diabetes; 1986 Oct; 35(10):1106-8. PubMed ID: 3019804 [TBL] [Abstract][Full Text] [Related]
12. Accumulation of sorbitol in the sciatic nerve modulates circadian properties of diabetes-induced neuropathic pain hypersensitivity in a diabetic mouse model. Akamine T; Kusunose N; Matsunaga N; Koyanagi S; Ohdo S Biochem Biophys Res Commun; 2018 Sep; 503(1):181-187. PubMed ID: 29864425 [TBL] [Abstract][Full Text] [Related]
13. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy. Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396 [TBL] [Abstract][Full Text] [Related]
14. Effects of a new aldose reductase inhibitor, (2S, 4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-ca rboxamid e (SNK-860), on the slowing of motor nerve conduction velocity and metabolic abnormalities in the peripheral nerve in acute streptozotocin-induced diabetic rats. Mizuno K; Kato N; Matsubara A; Nakano K; Kurono M Metabolism; 1992 Oct; 41(10):1081-6. PubMed ID: 1328819 [TBL] [Abstract][Full Text] [Related]
15. Action of sorbinil in diabetic peripheral nerve. Relationship of polyol (sorbitol) pathway inhibition to a myo-inositol-mediated defect in sodium-potassium ATPase activity. Greene DA; Lattimer SA Diabetes; 1984 Aug; 33(8):712-6. PubMed ID: 6086432 [TBL] [Abstract][Full Text] [Related]
17. The role of cyclic adenosine 3',5'-monophosphate and polyol metabolism in diabetic neuropathy. Shindo H; Tawata M; Aida K; Onaya T J Clin Endocrinol Metab; 1992 Feb; 74(2):393-8. PubMed ID: 1370506 [TBL] [Abstract][Full Text] [Related]
18. Na,K-atpase alterations in diabetic rats: relationship with lipid metabolism and nerve physiological parameters. Djemli-Shipkolye A; Coste T; Raccah D; Vague P; Pieroni G; Gerbi A Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):297-304. PubMed ID: 11355004 [TBL] [Abstract][Full Text] [Related]
19. Experimental diabetic neuropathy: role of oxidative stress and mechanisms involved. MartÃnez-Blasco A; Bosch-Morell F; Trenor C; Romero FJ Biofactors; 1998; 8(1-2):41-3. PubMed ID: 9699007 [TBL] [Abstract][Full Text] [Related]
20. Cyclic adenosine 3',5'-monophosphate enhances sodium, potassium-adenosine triphosphatase activity in the sciatic nerve of streptozotocin-induced diabetic rats. Shindo H; Tawata M; Onaya T Endocrinology; 1993 Feb; 132(2):510-6. PubMed ID: 7678791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]